The largest database of trusted experimental protocols

3 protocols using dmem ham s f12 3 1

1

Topical Application of Biofilm on Reconstructed Human Gingiva

Check if the same lab product or an alternative is used in the 5 most similar protocols
The stored biofilms were thawed on ice, centrifuged and dispersed in Hanks' balanced salt solution (HBSS, Sigma-Aldrich) (Spano et al., 2016 (link)). A sample of biofilm was processed to determine CFU count. The remaining biofilm was applied topically onto RHG, with ~1 × 107 CFU biofilm cells concentrated in a drop of 10 μl in HBSS as previously described (Buskermolen et al., 2017 (link)). The biofilm-RHGs were further cultured at the air liquid interface in medium containing DMEM/Ham's F12 (3/1) (Gibco, Grand Island, USA) supplemented with 1% Fetal Clone III (RHG, Logan, UT, USA), 0.1 μM insulin (Sigma-Aldrich, St. Louis, MO, USA), 2 μM hydrocortisone (Sigma-Aldrich), 1 μM isoproterenol (Sigma-Aldrich), 10 μM carnitine (Sigma-Aldrich), 10 mM L-serine (Sigma-Aldrich), 0.4 mM L-ascorbic acid (Sigma-Aldrich), and 2 ng/ml epidermal growth factor (Sigma-Aldrich), for 24 h at 37°C, 7.5% CO2 and 95% humidity. After 24-h exposure RHG were harvested.
+ Open protocol
+ Expand
2

Gingiva Epithelial-Fibroblast Co-Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immortalized gingiva keratinocyte (KC-TERT, OKG4/bmi1/TERT, Rheinwald laboratory, Boston, USA) (passage 10 to 20) and fibroblast (Fib-TERT, T0026, ABM, Richmond, BC, Canada) (passage 10 to 20) cell lines were used for constructing RHG. The RHG model, consisting of a fibroblast-populated collagen hydrogel (collagen I derived from rat tail) overlaid with keratinocytes (0.5 x 106 cells) was cultured exactly as previously described (Kosten et al., 2015 (link)). In brief, RHG were cultured in six-well transwell inserts (pore size 0.4μm, 24mm, Corning, USA), first submerged in culture medium for 3 days and then lifted to the air-liquid interface for an additional 10 days to induce epithelial differentiation and stratification in culture medium containing DMEM/Ham’s F12 (3/1) (Gibco, Grand Island, USA) supplemented with 1% Fetal Clone III (HyClone, GE Healthcare, Chicago, USA), 1% PS (Gibco, Grand Island, USA), 0.1µM insulin, 1µM hydrocortisone, 1µM isoproterenol, 10µM L-carnitine, 10mM L-serine, 0.4mM ascorbic acid, and 2ng/mL epidermal growth factor. All agents were purchased at Sigma-Aldrich (St. Louis, USA) when not specified. One day prior to bacteria exposure, PS and hydrocortisone were omitted in RHG culture medium for some experimental conditions as indicated below.
+ Open protocol
+ Expand
3

Isolation of Human Gingival Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Healthy human gingiva tissue was used in an anonymous manner in accordance with the “Code for Proper Use of Human Tissues” as formulated by the Dutch Federation of Medical Scientific Organizations (www.fmwv.nl). Primary gingiva KC and fibroblasts were isolated as previously described for skin.26–28 (link) In short, after overnight digestion in dispase II (Sigma-Aldrich) to separate the epithelial sheet from the lamina propria, gingiva KC (KC-Prim) were isolated from the epithelium with 0.05% trypsin/EDTA (Gibco) solution. KC were cultured in KC medium consisting of DMEM/Ham's F12 (3/1) (Gibco), supplemented with 5% Fetal Clone III (GE), 1% penicillin–streptomycin (Gibco), 1 μM hydrocortisone (Sigma-Aldrich), 0.1 μM insulin (Sigma-Aldrich), 1 μM isoproterenol (Sigma-Aldrich), and 1 ng/mL epidermal growth factor (EGF) (Sigma-Aldrich). KC-Prim were used until the third passage. Gingival fibroblasts (Fib-Prim) were isolated from the lamina propria by incubation in a collagenase type II (Gibco) solution and cultured in fibroblast medium consisting of DMEM, supplemented with 5% Fetal Clone III and 1% penicillin–streptomycin. The Fib-Prim were used between passage 3 and 4.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!